Cargando…
Lipid Alterations in Systemic Sclerosis
Background: Systemic sclerosis (SSc) is an autoimmune disease with an elusive etiology and poor prognosis. Due to its diverse clinical presentation, a personalized approach is obligatory and needs to be based on a comprehensive biomarker panel. Therefore, particular metabolomic studies are necessary...
Autores principales: | Gogulska, Zuzanna, Smolenska, Zaneta, Turyn, Jacek, Mika, Adriana, Zdrojewski, Zbigniew |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8724564/ https://www.ncbi.nlm.nih.gov/pubmed/34993231 http://dx.doi.org/10.3389/fmolb.2021.761721 |
Ejemplares similares
-
Metabolic Pattern of Systemic Sclerosis: Association of Changes in Plasma Concentrations of Amino Acid-Related Compounds With Disease Presentation
por: Smolenska, Zaneta, et al.
Publicado: (2020) -
Metabolomics and its potential in diagnosis, prognosis and treatment of rheumatic diseases
por: Smoleńska, Żaneta, et al.
Publicado: (2015) -
Hypertrophic pachymeningitis as an important neurological complication of granulomatosis with polyangiitis
por: Smoleńska, Żaneta, et al.
Publicado: (2018) -
Changes in Proliferation Kinetics of T Cells: A New Predictive Cellular Biomarkers for Early Rheumatoid Arthritis?
por: Pawłowska, Justyna, et al.
Publicado: (2012) -
New lung mass in a patient with granulomatosis with polyangiitis
por: Masiak, Anna, et al.
Publicado: (2020)